TGFB1 and neoplasm: Similarly, applying a TGF-β siRNA (siTGF-β) to tumor cells and CAFs significantly reduced their expression of TGF-β, helping to normalize the vascular system of the tumors, inhibiting EMT, and increasing the infiltration of immune cells [149].